Quarterly report pursuant to Section 13 or 15(d)

Supplemental Condensed Consolidated Balance Sheet Information

v3.24.3
Supplemental Condensed Consolidated Balance Sheet Information
9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Supplemental Condensed Consolidated Balance Sheet Information
7.
Supplemental Condensed Consolidated Balance Sheet Information

Accrued expenses and other current liabilities consist of the following:

 

 

 

September 30,
2024

 

 

December 31,
2023

 

Accrued consulting

 

$

78,447

 

 

$

49,395

 

Accrued compensation

 

 

653,230

 

 

 

635,451

 

Accrued research and development

 

 

1,416,647

 

 

 

1,472,292

 

Accrued other

 

 

13,050

 

 

 

102,817

 

Total accrued expenses and other current liabilities

 

$

2,161,374

 

 

$

2,259,955